Effects of adipose tissue derived stem cells on testicular injury in rats with experimental undescended testis.
Karadeniz Saygili S., Aydemir I., Ozkut MM., Abulimiti R., Firat F., Sal DH.
Animal Study with a reported sample of 20, published in J Mol Histol (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- J Mol Histol (2026)
- Country
- Netherlands
- Reported sample size
- 20
- Source database
- PubMed
- PMID
- 41546838
- DOI
- 10.1007/s10735-025-10696-w
Abstract (original English)
Undescended testes is a common medical condition that is often treated late because it is generally not recognized early. In delayed cases, the testes can be damaged by higher temperatures, which may lead to infertility and cancer. Various studies have shown that stem cells can be protective in testicular damage, and regardless of their intended use, they have generally shown a favorable safety profile in preclinical studies. Based on this data, the investigation focused on adipose-derived stem cell (ADSC) treatment to evaluate its protective effects on experimental undescended testis (EUT) damage. Forty male Wistar rats (16–19 days old) were divided into two experimental durations (3 days and 7 days, n = 20 for each duration). There were four groups in each period (n = 5/group): Control, EUT, EUT + medium (M), and EUT + ADSC. In EUT groups, the right testis was surgically affixed intra-abdominally. ADSC-treated rats were administered 1 × 106 ADSCs in 300 µL of medium injected into the rete testis. Histopathological assessment was conducted using hematoxylin–eosin staining and Johnsen’s grading system. We used eNOS/iNOS immunohistochemistry and the TUNEL test to check for oxidative stress and apoptosis, and VASA immunostaining to check for germ cells. The one-way ANOVA test was used for statistical analysis. A p-value of less than 0.05 was considered significant. In EUT applied
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.